WP4: Biobank Assessment

Helsinki University

Institute for Molecular Medicine Finland FIMM & Department of Public Health

Prof. Jaakko Kaprio

King’s College London

Institute of Psychiatry, Psychology & Neurosciences

Prof. Allan Young and Dr. Mario Juruena

  • Tel Aviv University
  • King’s College London

  • Big data will be obtained from Finnish and UK genetic databases to assess pharmacogenetic genotype and clinical outcomes in patients with mood-, anxiety or psychotic disorders to investigate real-world, large-scale and long-term perspectives on outcomes of specific disease – medication stratified by CYP2C19 and CYP2D6 genotype.